Biopharmaceutical Contract Manufacturing Market Sales, Key Players, Demands, Trends, Growth, Share, Size and Forecasts - PowerPoint PPT Presentation

About This Presentation
Title:

Biopharmaceutical Contract Manufacturing Market Sales, Key Players, Demands, Trends, Growth, Share, Size and Forecasts

Description:

FMI’s study on the biopharmaceutical contract manufacturing market offers information divided into five important segments - platform, product type, application, therapeutic area, and region. – PowerPoint PPT presentation

Number of Views:41
Slides: 9
Provided by: Umesh213
Category: Other

less

Transcript and Presenter's Notes

Title: Biopharmaceutical Contract Manufacturing Market Sales, Key Players, Demands, Trends, Growth, Share, Size and Forecasts


1

Biopharmaceutical Contract Manufacturing Market
Sales, Key Players, Demands, Trends, Growth,
Share, Size and Forecasts FMI Report
  • April 2021

Report Id REP-GB-2982 Published On
2020-01-23Category Healthcare, Pharmaceuticals
Medical Devices
2
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage
  • Customized Research
  • Syndicated Research
  • Investment Research
  • Social Media Research

  • Automotive and Transportation
  • Electronics, Semiconductor, and ICT
  • Retail and Consumer Products
  • Industrial Automation and Equipment
  • Chemicals Materials
  • Food and Beverages
  • Services and Utilities
  • Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email hari.t_at_futuremarketinsights.co
m
3
Research Methodology (1/2)
  • Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)
  • Identifying key opinion leaders
  • Questionnaire design
  • In-depth interviews
  • Coverage across value chain
  • Key industry experts
  • Channel study
  • Developments
  • Market dynamics
  • Products
  • Conclusions

SOLUTION
  • Market participants
  • Key strengths
  • Product portfolio
  • Mapping as per value chain
  • Key focus segments

Primary Research
Secondary Research
Paid Publications
  • Linkedin
  • Zoominfo
  • Salesforce
  • Avention
  • Factiva
  • GBI
  • Genios
  • Meltwater
  • Company websites
  • Company annual reports
  • White papers
  • Financial reports

includes sources of databases
4
Biopharmaceutical Contract Manufacturing Market
Analysis
A new study on the global biopharmaceutical
contract manufacturing market by FMI discusses
some interesting aspects of the differentiating
strategies of key market players. Top
biomanufacturing companies in North
America and Europe are focussing on market
collaborations and agreements as key business
strategies for growth and expansion across the
globe. These companies are also acquiring small
scale biopharmaceuticals companies in the Asia
Pacific region to strengthen their market
presence. FMI presents several useful insights
and a comprehensive revenue forecast of the
global biopharmaceutical contract manufacturing
market in a new report titled "Biopharmaceutical
Contract Manufacturing Market Global Industry
Analysis 2012-2016 and Opportunity Assessment
2017-2027" along with information on the factors
influencing revenue growth of the market over a
10 year assessment period from 2017 to 2027.
The global biopharmaceutical contract
manufacturing market is estimated to be valued
at US 5,625.0 Mn by the end of 2017 and this is
expected to increase to US 15,467.8 Mn by the
end of 2027, registering a CAGR of 10.6 in terms
of value over the forecast period. Global Market
Research Report Overview on Biopharmaceutical
Contract Manufacturing_at_  https//www.futuremarketi
nsights.com/reports/biopharmaceutical-contract-man
ufacturing-market
5
Biopharmaceutical Contract Manufacturing Market
Analysis
Global Biopharmaceutical Contract Manufacturing Ma
rket Regional Forecast  The global
biopharmaceutical contract manufacturing market
has been studied across the key regions of North
America, Latin America, Western Europe, Eastern
Europe, Asia Pacific excluding Japan, Japan,
and Middle East  Africa. North America is the
largest regional market, estimated to be valued
at US 5,039.3 Mn by 2027 end, with a CAGR of
9.8. APEJ is the second largest market for
biopharmaceutical contract manufacturing, with a
growth rate of 12.2 anticipated during the 10
year forecast period. Global Biopharmaceutical
Contract Manufacturing Market Forecast by
Platform  The report segments the global
biopharmaceutical contract manufacturing market
on the basis of Platform into Mammalian and
Microbial. Mammalian is the largest segment by
platform, which is estimated to represent US
3,857.2 Mn or 68.6 share of the total market in
2017 and is projected to reach US 12,534.5 Mn or
81.0 share by 2027 end, expanding at a CAGR of
12.5 over the forecast period. View Report
Table of Contents, Figures, and Tables_at_ https//ww
w.futuremarketinsights.com/reports/biopharmaceutic
al-contract-manufacturing-market/toc
6
Biopharmaceutical Contract Manufacturing Market
Analysis
Global Biopharmaceutical Contract Manufacturing
Market Forecast by Product Type  In terms of
product type, the global biopharmaceutical
contract manufacturing market is segmented into
Growth Factors, Interferons, Monoclonal
Antibodies, Recombinant Hormones, Vaccines,
Insulin, and Others. Monoclonal Antibodies is the
largest segment by product type, with revenues
estimated to cross US 8,100 Mn by the end of the
forecast period and a CAGR of 11.3.
Global Biopharmaceutical Contract Manufacturing
Market Forecast by Application  The global
biopharmaceutical contract manufacturing market
is segmented on the basis of application into
Clinical and Commercial. The Commercial segment
will dominate the global market, with revenues in
excess of US 12,000 Mn expected to be recorded
by the end of 2027 resulting in a CAGR of 11.0.
7
Biopharmaceutical Contract Manufacturing Market
Analysis
Global Biopharmaceutical Contract Manufacturing
Market Forecast by Therapeutic Area  On the
basis of therapeutic area, the global
biopharmaceutical contract manufacturing market
is segmented into Autoimmune Diseases, Oncology,
Metabolic Diseases, Ophthalmology, Cardiovascular
Diseases, Infectious Diseases, Neurology,
Respiratory Disorders, and Others. Oncology is
the largest segment by therapeutic area, expected
to be valued at US 1,111.1 Mn by the end of
2017. Oncology is also the most lucrative
segment. Autoimmune Diseases is the second
largest segment by therapeutic area with a market
attractiveness index of 1.3.
Global Biopharmaceutical Contract Manufacturing
Market Competitive Landscape  The report
features some of the leading companies operating
in the global biopharmaceutical contract
manufacturing market. Companies profiled include
Lonza Group AG, Baxter Biopharma Solutions,
Samsung Biologics Co., Ltd., Fujifilm Diosynth
Biotechnologies, Boehringer Ingelheim GmbH,
Patheon N.V., Rentschler Biotechnologie GmbH,
Biomeva GmbH, Probiogen AG, Cytovance Biologics,
Inc., KBI Biopharma, Inc., WuXi Biologics, Abzena
Plc, Vetter Pharma International GmbH, Sandoz
International GmbH, Catalent, Inc., AbbVie
Contract Manufacturing (An AbbVie Company),
Ajinomoto Althea, Inc.
8
To know more about us, please visit our website
www.futuremarketinsights.com For sales queries
or new topics email us on sales_at_futuremarketinsi
ghts.com For media queries, contact the press
office at press_at_futuremarketinsights.com For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email hari.t_at_futuremarketinsights.com
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)
Write a Comment
User Comments (0)
About PowerShow.com